The verdict capped years of investigation and a convulsion of shock at the many deaths in this small Central American nation.
Officials say 400 people died when they drank the adulterated cough syrup, which had been mixed and distributed by the national health agency using an ingredient supplied by a private company, Medicom.
Some Panamanian organisations believe as many as 10,000 people may have died from the medicine.
Medicom had bought the ingredient, labeled "TD glycerin", from a Spanish pharmaceutical firm, Rasfer International, which had purchased it from a Chinese group, CNSC Fortune Way Company, which had sourced it from the Taixing Glycerine Factory.
The compound can be used as a solvent, in brake fluid, or in heating fuel, and is often found in automobile antifreeze.
The scandal triggered investigations in Panama, Spain and China.
In Panama, 26 people were charged over the matter, with 11 of them prosecuted.
The legal representative of Medicom in Panama, Angel Ariel de la Cruz Soto, yesterday was sentenced to five years in prison and fined USD 6,000.
The four other people sentenced received terms of one year. Six people were acquitted.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
